GEODE CAPITAL MANAGEMENT, LLC
Position in RANI — Rani Therapeutics Holdings, Inc.
CIK 1214717
BOSTON, MA
Position in RANI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$676,869
+$12,946 QoQ
Shares Held
890,618
-1.4% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 67 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RANI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. RANI ranks #344 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RANI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $676,869 | 890,618 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $663,923 | 903,298 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,162,270 | 860,941 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $148,455 | 296,910 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $97,945 | 190,557 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $247,232 | 196,217 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $235,054 | 171,573 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $372,083 | 172,261 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $572,788 | 150,734 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $407,117 | 130,906 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $377,248 | 113,629 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $247,143 | 113,629 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $400,402 | 97,185 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $501,474 | 97,185 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $573,391 | 97,185 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $905,616 | 94,532 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $758,728 | 73,449 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $962,091 | 71,266 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,033,597 | 63,217 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $385,606 | 21,639 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||